+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

O

Actively Recruiting

Researchers are collecting real-world data to evaluate the use of SuperSaturated Oxygen SSO2 Therapy compared to standard care with PCI alone in patients who have had an anterior acute myocardial infarction AMI. This observational study aims to understand the therapys impact on heart failure burden, infarct size reduction, and overall healthcare costs. The study will also help confirm how SSO2 Therapy affects infarct size compared to usual treatment. Participants will be observed in two groups those treated with SSO2 Therapy and those not treated with it. The study involves routine clinical care with some patients receiving SSO2 Therapy at the physicians discretion before enrollment. A subset of patients may undergo cardiac MRI scans to assess heart damage more closely. Quality of life questionnaires, such as the KCCQ and EQ5D, will be used to assess patient well-being. During the study, participants will have their health monitored through medical records and questionnaires over time. The primary outcomes include cardiovascular death or heart failure burden measured at a median of 1.5 years and infarct size assessed 2 to 7 days after PCI. Secondary outcomes include mortality rates, hospitalizations, and changes in quality of life scores over 2 years. Data collected will support analysis of the therapys effectiveness and cost-effectiveness, with study participation lasting until the planned end date in 2029.

Age: 18Years - 80YearsAll Genders
27 locations